Veronika Sexl (born February 27, 1966) is an Austrian pharmacologist and toxicologist with interests in cancer research.[1] Since March 1, 2023 she is rector of the University of Innsbruck.[2]
Her main research areas include: comparative and translational medicine using transgenic animals and human patient samples as disease models; NK cell mediated tumor surveillance with a focus on leukemia; signaling pathways involved in hematopoiesis and leukemogenesis with a focus on JAK-STAT signaling and on the novel role of CDK6 as transcriptional regulator.[1]
Awards
edit- 2004: Billroth Award of the Austrian Medical Association[1]
- 2005: Novartis Prize for Medicine[1]
- 2006: Alois Sonnleitner Prize of the Austrian Academy of Sciences (ÖAW)[1]
- 2008" “Major Central European Prize of the City of Vienna Fund for innovative interdisciplinary cancer research” - Major Award for Cancer Research of the Vienna Fund[1]
- 2015: Elected member of the Austrian Academy of Sciences (OAW)[1]
- 2017: Award for Medical Sciences of the City of Vienna[1]